Tomás Soulé, Clinical Oncologist at IAF (Alexander Fleming Institute), shared on LinkedIn:
“Today I had the opportunity to participate in the Latin American Advisory Board on nirogacestat, where specialists from across the region discussed how this new therapeutic option may be integrated into the management of patients with desmoid tumors.
Beyond the scientific discussions, what I value most is the opportunity to exchange ideas with colleagues I have admired for many years.
It was a privilege to share this meeting with Bernd Kasper , one of the world’s leading experts in sarcoma, as well as with so many colleagues committed to advancing the care of patients with sarcomas and desmoid tumors.
Grateful for the invitation and for such an enriching exchange of ideas.”
Other articles about cancer types on OncoDaily.